CH Paul-Brousse (APHP)

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Deep vein thrombosis and pulmonary embolism
• Myeloproliferative neoplasms

Running trials

• Recruiting

  AVAJAK: Apixaban/Rivaroxaban Versus Aspirin for Primary Prevention of Thrombo-embolic Complications in JAK2V617F-positive Myeloproliferative Neoplasms

  NCT05198960· Phase 3· University Hospital, Brest· Source

  Contact: Laurence LE GROS, PH

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Deep vein thrombosis and pulmonary embolism1 recruiting
• Myeloproliferative neoplasms1 recruiting